This article was originally published in The Gray Sheet
Influenza test is categorized as a moderate complexity test by the Centers for Disease Control and Prevention. "The Gray Sheet" (Oct. 4, p. 5) incorrectly stated the test was CLIA-waived
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.